Top compounds associated with response to USP17L7


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA tigecycline CTRPv2 pan-cancer AAC 0.067 0.2
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC 0.053 0.2
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA tosedostat CTRPv2 pan-cancer AAC -0.049 0.2
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.063 0.2
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.05 0.2
Download CSV